Brimhall Logo
- 0 Items

May 31, 2021 - 18 Teens Hospitalized with heart problems after...


May 31, 2021 Puzzle Piece

18 Teens Hospitalized with heart problems after...

I am sending you these articles without comment for your review.

(This is from 2 separate but related Medpage articles.) 

This is a comment from Medpage on April 26, 2021 by Council Rudolph:

All Covid-19 vaccines are experimental treatments.  They all focus on the spike protein of the virus COVID-19 carries on its surface.  As humans, we carry spike proteins too.  A woman’s placenta when she’s pregnant, carries a bunch.  A man’s spike proteins are concentrated in our testicular tissues, especially those that produce sperm.  That’s why the Corona Virus vaccine of 2014 produced a profoundly effective infertility results, and why it was shut down by the FDA.
Some physicians say: “That’s also why the COVID-19 will also produce a profound infertility in men and in women, by producing antibodies to attack our own cell.  That’s called autoimmunity.  And now we are talking of giving this vaccine to our children.  Here we go again, 2+2=5.”
This is a comment to the article below.  It is in Medpage Today in the ‘Comment’ section. 
All comments are reviewed and approved by Medpage before being added. 


Healthcare Professional: ALL

David Montieth

May 25, 2021

While Moderna's announcement of 100% efficacy with teens 12-17 years old sounds very positive, it was just announced in Connecticut that 18 teens have been hospitalized with heart problems following their Covid-19 vaccination, most within 4 days of their 2nd shot. The announcement did not indicate whose vaccines were used by these teens. If we shut down J&J vaccines after 7 adults in the entire country had blood clots, shouldn't we do the same when 18 youth in one of the smallest states in the U.S. had heart problems?


Moderna Boasts High Efficacy for COVID Vax in Teens

— Prevented symptomatic illness in TeenCOVE, manufacturer says

by Molly Walker, Deputy Managing Editor, MedP

age Today May 25, 2021

Moderna's COVID-19 vaccine showed 100% efficacy in adolescents ages 12 to 17, according to a press release from the manufacturer on Tuesday.

Starting 14 days after the second dose of vaccine, no cases of COVID-19 were reported in the vaccine group compared to control group.

"We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents. It is particularly exciting to see that the Moderna COVID-19 vaccine can prevent SARS-CoV-2 infection," said Moderna CEO Stéphane Bancel in a statement.

Examining safety, the vaccine had a consistent profile to that seen in adults, with injection site pain as the most common local adverse event, and headache, fatigue, myalgia, and chills as the most common systemic reactions following the second dose.

Moderna also said they plan to submit the data to a peer-reviewed publication.

Last Updated May 25, 2021

Molly Walker is deputy managing editor and covers infectious diseases for Medpage Today. She is a 2020 J2 Achievement Award winner for her COVID-19 coverage.

NOTE: nothing in the article about side effects.

It seems there is a lot to learn…

Yours in Health and Wellness,
John W Brimhall, DC, BA, BS, FIAMA, DIBAK

Customer Reviews
# of Ratings: 0
There are no comments for this product.